N Engl J Med
2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingAntibodies, Viral
Dr. Barbara Eve Rizzardi, MD
NPI1245385319
- Part D claims, 2020
- 1,168
- Publications
- 3
- Clinical trials
- 11
- Industry payments
- $37,116
- State license
- 1
- Practice address
- 1434 E 9400 S, Sandy, UT 84093-2957
- Practice phone
- Call (801) 576-8333
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Rizzardi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Barbara Eve Rizzardi is an internist in Sandy, Utah
Dr. Rizzardi practices in Sandy, Utah.
Dr. Rizzardi's NPI, 1245385319, was assigned on January 25, 2007. Dr. Rizzardi holds Utah license 168256.
NPI and contact details
- NPI
- 1245385319NPI Registry (opens in a new tab)
- NPI enumeration date
- January 25, 2007
- NPI status
- Active
- Practice phone
- (801) 576-8333
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Barbara Eve Rizzardi's practice address is in Sandy, Utah
Dr. Rizzardi's practice address in the NPI Registry is 1434 E 9400 S, Sandy, UT 84093-2957. The practice phone is (801) 576-8333.
- NPI Registry address1434 E 9400 S, Sandy, UT 84093-2957Phone(801) 576-8333
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Barbara Eve Rizzardi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizzardi practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Rizzardi's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Rizzardi practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Barbara Eve Rizzardi is one of 663 internists in Utah
Internal medicine is Dr. Rizzardi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rizzardi is licensed in Utah.
Specialties and state licenses
- Internal medicine, UtahPrimary
Internists near Dr. Rizzardi
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Barbara Eve Rizzardi's patients have a median age of 67
Across all payers, Dmand AI patient panel data puts Dr. Rizzardi's median patient age at 67, with 64% women.
Dr. Rizzardi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women64%
- Men36%
Source: Dmand AI Patient Panel Data
Dr. Barbara Eve Rizzardi wrote 1,168 Medicare Part D claims in 2020
In 2020, Dr. Rizzardi wrote 1,168 Medicare Part D claims. They cover 41 drugs, with $85,565 in total drug cost. In 2019, CMS named 1,832 claims across 60 drugs.
Part D claims, 20201,168
Drugs named by CMS41
Total drug cost$85,565
Dr. Rizzardi's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 1,8322020: 1,16836%
Drugs named by CMS: 41 in 2020, 60 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find internists like Dr. Rizzardi by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Barbara Eve Rizzardi has 3 publications on record
Dmand AI links 3 papers to Dr. Rizzardi, published from 2022 to 2023. The most frequent topics are Double-Blind Method. Dr. Rizzardi's most frequent co-authors are Kimball Anne Johnson, MD, Kashif Rahat Ali, MD and Madhavi Ampajwala, MD.
Papers3
Years published2022 to 2023
Topics Dr. Rizzardi writes about most
- Double-Blind Method
Dr. Rizzardi's most frequent co-authors
- Kimball Anne Johnson, MD2 shared papers
- Kashif Rahat Ali, MD1 shared paper
- Madhavi Ampajwala, MD1 shared paper
Recent publications by Dr. Rizzardi
DiphtheriaDiphtheria-Tetanus-acellular Pertussis VaccinesDouble-Blind Method
See who Dr. Rizzardi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rizzardi works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Barbara Eve Rizzardi has worked on 11 clinical trials
Dmand AI links Dr. Rizzardi to 11 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Anthrax, Celiac Disease and Chikungunya Fever. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Rizzardi that name 5 trials.
Clinical trials with Dr. Rizzardi by phase
- 1Phase 1: 1 trial
- 4Phase 2: 4 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Rizzardi's trials
- Anthrax
- Celiac Disease
- Chikungunya Fever
- Glomerulonephritis, IGA
- Influenza, Human
Investigators on the most trials with Dr. Rizzardi
- Cory G. Anderson, MD5 shared trials
- Judith L. Kirstein, MD4 shared trials
- Steven Earl Cox, DO3 shared trials
Recent clinical trials with Dr. Rizzardi
Celiac DiseaseMalabsorption SyndromesKAN-101
Influenza, HumanOrthomyxoviridae InfectionsAS03AAS03BFLU-Q-PAN H7N9 Formulation 1
Osteoporosis, PostmenopausalOsteoporosisAbaloparatideAbaloparatide solid microstructured transdermal system
A Phase IIb, Randomized, Observer-Blind Study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents (opens in a new tab)
Active, not recruitingPhase 2
Meningitis, MeningococcalCentral Nervous System Bacterial InfectionsMenABCWY vaccine
Premature EjaculationEjaculatory DysfunctionPSD502
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Barbara Eve Rizzardi received $37,116 in industry payments from 2016 to 2025
CMS Open Payments shows 460 general payments to Dr. Rizzardi from 41 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. Genentech, Inc. paid the most, $11,580. It also lists 37 research payments totaling $251,626 from 2022 to 2025, naming 5 clinical trials.
General payments to Dr. Rizzardi by program year, 2016 to 2025
General payments to Dr. Rizzardi by kind, 2016 to 2025
$37.1Kin total
- Travel and lodging$25,08768%
- Food and beverage$12,00732%
- Education$230%
Companies that paid Dr. Rizzardi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Barbara Eve Rizzardi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Barbara Eve Rizzardi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Barbara Eve Rizzardi's NPI number?
Dr. Barbara Eve Rizzardi's NPI number is 1245385319. It was assigned on January 25, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Barbara Eve Rizzardi?
Dr. Barbara Eve Rizzardi is an internist in Sandy, Utah. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Barbara Eve Rizzardi practice?
Dr. Rizzardi practices at 1434 E 9400 S, Sandy, UT 84093-2957.
What is Dr. Barbara Eve Rizzardi's office phone number?
The practice phone on file for Dr. Rizzardi is (801) 576-8333.
What is Dr. Barbara Eve Rizzardi's medical license number?
Dr. Rizzardi holds Utah license 168256.
What drugs does Dr. Barbara Eve Rizzardi prescribe most?
In 2020 Medicare Part D data, Dr. Rizzardi's most prescribed drugs by claims were Atorvastatin Calcium, Levothyroxine Sodium and Gabapentin.
Has Dr. Barbara Eve Rizzardi received payments from drug or device companies?
CMS Open Payments shows $37,116 in general payments to Dr. Rizzardi from 41 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Barbara Eve Rizzardi been practicing?
Dr. Rizzardi's NPI was assigned in 2007.
Does Dr. Barbara Eve Rizzardi do research?
Dmand AI links 3 publications to Dr. Rizzardi, published from 2022 to 2023. Dr. Rizzardi has worked on 11 clinical trials.
Who does Dr. Barbara Eve Rizzardi publish with?
Dr. Rizzardi's most frequent co-authors are Kimball Anne Johnson, MD (2 shared papers), Kashif Rahat Ali, MD (1 shared paper) and Madhavi Ampajwala, MD (1 shared paper).
Selling to internal medicine practices?
See internists in Utah by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card